Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals CVS Caremark by Year
CVS Caremark — Share of gross product revenues (historical, %) (%)
Vertex Pharmaceuticals CVS Caremark: 1,000.0% in FY2017, down 900.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
Source: Form 10-K (filed 2019-02-13) ↗
Reported in Form 10-K Note (Significant Revenue & Receivable Concentrations).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CVS Caremark — Share of gross product revenues (historical, %) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | 1,000.0% | -900.0 pts | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 1,900.0% | +200.0 pts | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 1,700.0% | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals CVS Caremark (%), annual FY2015–FY2017 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/conc-cvs-rev
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.